GUTS Fractyl Health, Inc.
$1.07▼ -0.93%
Healthcare
Other
Volume 361.2K
Avg Volume (10D) 1.93M
Key Metrics & Fundamentals
Market Cap
$14.19M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.02 - 29.34
% vs 50 MA
-82.29%
% vs 200 MA
-87.17%
RSI-14
15.2
MACD Histogram
-0.1900
Beta (1Y vs SPY)
2.45
Free Cash Flow
-$15.90M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$13.33M
COGS
–
Operating Exp
$19.10M
Operating Income
-$19.10M
EBIT
-$19.10M
Pretax Income
-$25.54M
Net Income
-$25.54M
EPS (Diluted)
-0.16
Price & Volume History
Loading chart…
Recent News
Fractyl Health (GUTS) Stock Sees Fair Value Cut After Mixed Revita Analyst Reactions
Simply Wall St. · Oct 22, 2026 9:11 AM ET
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
GlobeNewswire · Oct 22, 2026 7:00 AM ET
Fractyl Health Meets Six-Month Primary Endpoint in Revita Obesity Trial, Supporting FDA Submission Plans
InvestorsHub · Oct 16, 2026 9:32 AM ET
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
GlobeNewswire · Oct 16, 2026 7:00 AM ET
Fractyl Health to Participate in Upcoming September Investor Conferences
GlobeNewswire · Sep 9, 2026 7:00 AM ET
Fractyl Health Eyes 2028 Revita Launch for Post-GLP-1 Weight Maintenance
MarketBeat · Sep 1, 2026 5:01 PM ET
Fractyl Health shares rise 2.8% ahead of Virtual Commercial Strategy Day
InvestorsHub · Sep 1, 2026 8:56 AM ET
Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance
GlobeNewswire · Aug 20, 2026 7:00 AM ET
Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial
MarketBeat · Aug 14, 2026 5:04 AM ET
Fractyl Health, Inc. Common Stock Q2 2026 Earnings Call Summary
Moby · Aug 11, 2026 9:50 PM ET
Financial Overview - Income Statement
Quarterly
Dec 2024
See GUTS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.